Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Breast Cancer Research and Treatment
|
November 27, 2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer
Sophia Zelizer, Grace B Gallagher, Mithat Gonen, et al.
Annals of Surgical Oncology
|
March 18, 2015
Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Maxine S Jochelson, Katharine Lampen-Sachar, Girard Gibbons, et al.
International Journal of Clinical Pharmacy
|
September 22, 2025
Economic evaluation of hepatitis B screening in low- and middle-income countries: a systematic review
Ha Thi Nguyen, Phuong Thi Lan Nguyen, Trinh Viet Ngo, et al.
Veterinary World
|
October 3, 2022
Effect of housefly (<i>Musca domestica</i>) larvae on the growth performance and carcass characteristics of local chickens in Niger
Bachir Hamani, Nassim Moula, Adamou Guisso Taffa, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Simultaneous Determination of Paracetamol, Ibuprofen, and Caffeine in Tablets by Molecular Absorption Spectroscopy Combined with Classical Least Square Method
Binh Thuc Tran, Tuyen Ngoc Tran, Ai My Thi Tran, et al.
International Journal of Molecular Sciences
|
August 27, 2021
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: <i>Dangerous Liaisons</i>
Paola Sini, Thi Bang Chau Dang, Milena Fais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 5, 2016
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
Gary A Ulaner, Debra A Goldman, Mithat Gönen, et al.
The Oncologist
|
March 19, 2017
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function
Filipa Lynce, Ana Barac, Ming T Tan, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review
Edith A Perez, Chau Dang, Caleb Lee, et al.
Archives of Pathology & Laboratory Medicine
|
October 25, 2019
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With <i>HER2</i>/CEP17 Ratio <2.0 and Average <i>HER2</i> Copy Number ≥4.0 and <6.0
Raza S Hoda, Edi Brogi, Jin Xu, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Breast Cancer Research and Treatment
|
November 27, 2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer
Sophia Zelizer, Grace B Gallagher, Mithat Gonen, et al.
Annals of Surgical Oncology
|
March 18, 2015
Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Maxine S Jochelson, Katharine Lampen-Sachar, Girard Gibbons, et al.
International Journal of Clinical Pharmacy
|
September 22, 2025
Economic evaluation of hepatitis B screening in low- and middle-income countries: a systematic review
Ha Thi Nguyen, Phuong Thi Lan Nguyen, Trinh Viet Ngo, et al.
Veterinary World
|
October 3, 2022
Effect of housefly (<i>Musca domestica</i>) larvae on the growth performance and carcass characteristics of local chickens in Niger
Bachir Hamani, Nassim Moula, Adamou Guisso Taffa, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Simultaneous Determination of Paracetamol, Ibuprofen, and Caffeine in Tablets by Molecular Absorption Spectroscopy Combined with Classical Least Square Method
Binh Thuc Tran, Tuyen Ngoc Tran, Ai My Thi Tran, et al.
International Journal of Molecular Sciences
|
August 27, 2021
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: <i>Dangerous Liaisons</i>
Paola Sini, Thi Bang Chau Dang, Milena Fais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 5, 2016
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
Gary A Ulaner, Debra A Goldman, Mithat Gönen, et al.
The Oncologist
|
March 19, 2017
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function
Filipa Lynce, Ana Barac, Ming T Tan, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review
Edith A Perez, Chau Dang, Caleb Lee, et al.
Archives of Pathology & Laboratory Medicine
|
October 25, 2019
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With <i>HER2</i>/CEP17 Ratio <2.0 and Average <i>HER2</i> Copy Number ≥4.0 and <6.0
Raza S Hoda, Edi Brogi, Jin Xu, et al.
Page
of 8